Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04539002 · ClinicalTrials.gov registry record · Phase 1
Aerobic Exercise for Remyelination in Multiple Sclerosis
A Phase 1 study, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- Phase 1
- Development phase
- 60
- Enrollment target
NCT04539002 is a Phase 1 study that has completed, run by Oregon Health and Science University. The registered enrollment target is 60 participants.
The verdict
NCT04539002, a Phase 1 study, has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 60 participants
- Enrollment target
Study Summary
This is a clinical trial to determine the feasibility of a stationary aerobic cycling intervention and explore if aerobic exercise independently promotes remyelination in people with multiple sclerosis (MS).
Interventions
- BEHAVIORAL Aerobic exercise
- BEHAVIORAL Education Group Control
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2021-04-29 |
| Est. Completion | 2025-03-27 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04539002
The ClinicalTrials.gov registry entry for NCT04539002 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Aerobic exercise is the first listed.
NCT04539002 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04539002 about?
NCT04539002 is a clinical study titled "Aerobic Exercise for Remyelination in Multiple Sclerosis". This is a clinical trial to determine the feasibility of a stationary aerobic cycling intervention and explore if aerobic exercise independently promotes remyelination in people with multiple sclerosis (MS).
What is the current status of trial NCT04539002?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 60 participants. The study started on 2021-04-29. Estimated completion is 2025-03-27.
What interventions are being tested in trial NCT04539002?
The interventions under investigation include: Aerobic exercise (BEHAVIORAL), Education Group Control (BEHAVIORAL).
Who is sponsoring clinical trial NCT04539002?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.